NLRB v. Kentucky River Community Care, Inc.

Columbia Care Introduces National Cannabis Loyalty Mobile App Across 14 Markets and Portfolio of Retail Brands

Retrieved on: 
Tuesday, August 2, 2022

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (Columbia Care or the Company), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced today that its national cannabis shopping and loyalty mobile app, Stash Cash , is now available on the Apple Store in 14 of its markets, and across its retail brands, including Cannabist, Columbia Care, The Green Solution and Project Cannabis.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (Columbia Care or the Company), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced today that its national cannabis shopping and loyalty mobile app, Stash Cash , is now available on the Apple Store in 14 of its markets, and across its retail brands, including Cannabist, Columbia Care, The Green Solution and Project Cannabis.
  • It is this passion that led to Forage, our proprietary cannabis discovery tool, as well as Cannabist, our award-winning retail brand.
  • Were proud of the entire team that brought this to life and coordinated its launch across 14 markets, 68 dispensaries and six retail brands.
  • In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms.

Columbia Care to Report Second Quarter 2022 Results on August 15, 2022

Retrieved on: 
Thursday, July 28, 2022

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (Columbia Care or the Company) today announced that it will report its financial results for the second quarter ended June 30, 2022 before U.S. financial markets open on Monday, August 15, 2022.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (Columbia Care or the Company) today announced that it will report its financial results for the second quarter ended June 30, 2022 before U.S. financial markets open on Monday, August 15, 2022.
  • Following the release of financial results, Company management will conduct a conference call at 8:00 a.m. EST to discuss financial and operating results for the second quarter of 2022.
  • After registering, instructions will be shared on how to join the call for those who wish to dial in.
  • Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.

Columbia Care Obtains Final Order of the Supreme Court of British Columbia Approving Business Combination with Cresco Labs

Retrieved on: 
Friday, July 15, 2022

The final order follows on achieving overwhelming shareholder approval for the business combination at the special meeting of shareholders of the Company held on July 8, 2022.

Key Points: 
  • The final order follows on achieving overwhelming shareholder approval for the business combination at the special meeting of shareholders of the Company held on July 8, 2022.
  • This final order is yet another milestone achieved towards creating the industry leader in cannabis, and were pleased with the forward progress in completing the transformational combination with Cresco, said Nicholas Vita, Co-Founder, CEO of Columbia Care.
  • With this final order in hand, we are now focused on continued momentum in the divestiture process and state-level approvals.
  • As previously announced, in certain states namely Florida, Illinois, Maryland, Massachusetts, New York, and Ohio Columbia Care and Cresco Labs will divest assets for regulatory approval prior to close.

Leading Independent Advisory Firm Glass Lewis Joins ISS in Recommending Columbia Care Shareholders Vote FOR the Transaction with Cresco Labs

Retrieved on: 
Thursday, June 30, 2022

Institutional Shareholder Services (ISS) has also recommended that shareholders vote in support of the transaction.

Key Points: 
  • Institutional Shareholder Services (ISS) has also recommended that shareholders vote in support of the transaction.
  • We are pleased that Glass Lewis also supports our Boards unanimous recommendation that shareholders vote FOR the transaction with Cresco, said Nicholas Vita, Co-Founder, CEO of Columbia Care.
  • In connection with the proposed transaction, Columbia Care has filed the Circular containing important information about the proposed transaction and related matters.
  • Additionally, Columbia Care and Cresco will file other relevant materials in connection with the proposed transaction with applicable securities regulatory authorities.

Leading Independent Advisory Firm ISS Recommends Columbia Care Shareholders Vote FOR the Transaction with Cresco Labs

Retrieved on: 
Wednesday, June 29, 2022

We are pleased that ISS supports our Boards unanimous recommendation that shareholders vote FOR the transaction with Cresco, said Nicholas Vita, Co-Founder, CEO of Columbia Care.

Key Points: 
  • We are pleased that ISS supports our Boards unanimous recommendation that shareholders vote FOR the transaction with Cresco, said Nicholas Vita, Co-Founder, CEO of Columbia Care.
  • The Columbia Care Board of Directors unanimously recommends that shareholders vote FOR the Arrangement.
  • In connection with the proposed transaction, Columbia Care has filed the Circular containing important information about the proposed transaction and related matters.
  • Additionally, Columbia Care and Cresco will file other relevant materials in connection with the proposed transaction with applicable securities regulatory authorities.

Columbia Care Announces Date of Special Meeting of Shareholders and Receipt of Interim Order

Retrieved on: 
Wednesday, June 15, 2022

The record date for the special meeting of shareholders was May 10, 2022.

Key Points: 
  • The record date for the special meeting of shareholders was May 10, 2022.
  • The proposed Arrangement Agreement has been unanimously approved by Columbia Cares Board of Directors and by a special committee of independent directors of Columbia Care, which was appointed by the Columbia Care Board of Directors.
  • The Columbia Care Board of Directors unanimously recommends that shareholders vote FOR the Arrangement.
  • The Circular will be mailed to Columbia Care shareholders and will be accessible via EDGAR and SEDAR.

Columbia Care Operationalizes Second Cultivation Facility in New Jersey and Expands Adult Use Hours at Both Garden State Cannabist Locations

Retrieved on: 
Tuesday, June 7, 2022

Both Cannabist locations began adult use sales on April 21 as one of the first seven operators to receive initial approval in the state and have continued to expand their hours.

Key Points: 
  • Both Cannabist locations began adult use sales on April 21 as one of the first seven operators to receive initial approval in the state and have continued to expand their hours.
  • In addition to the new 270,000-square-foot cultivation, manufacturing and processing facility, the Company also operates a 50,000-square-foot facility, also located in Vineland.
  • For more information on Cannabist locations, hours and menu availability in New Jersey, visit gocannabist.com/newjersey.
  • Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.

Columbia Care to Present at Cannabis Conference on June 7, 2022

Retrieved on: 
Friday, June 3, 2022

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (Columbia Care or the Company) today announced that Nicholas Vita, Co-Founder, Chief Executive Officer and Director, will participate in a fireside chat at the VirtualInvestorConferences.com Cannabis Conference on Tuesday, June 7, at 12:30 p.m.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (Columbia Care or the Company) today announced that Nicholas Vita, Co-Founder, Chief Executive Officer and Director, will participate in a fireside chat at the VirtualInvestorConferences.com Cannabis Conference on Tuesday, June 7, at 12:30 p.m.
  • The presentation webcast will be available on the Columbia Care website at http://ir.col-care.com .
  • Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU.
  • Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.

iAnthus Announces Appointment of Replacement Interim Chief Executive Officer and Director and Provides Update on Recapitalization Transaction

Retrieved on: 
Friday, May 6, 2022

NEW YORK and TORONTO, May 6, 2022 /PRNewswire/ -iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, announces the appointment of a replacement Interim Chief Executive Officer ("CEO") and member of the Company's Board of Directors (the "Board"), provides details of former Interim CEO, President and Director, Randy Maslow's separation agreement and provides an update with respect to its previously announced recapitalization transaction (the "Recapitalization Transaction").

Key Points: 
  • NEW YORK and TORONTO, May 6, 2022 /PRNewswire/ -iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, announces the appointment of a replacement Interim Chief Executive Officer ("CEO") and member of the Company's Board of Directors (the "Board"), provides details of former Interim CEO, President and Director, Randy Maslow's separation agreement and provides an update with respect to its previously announced recapitalization transaction (the "Recapitalization Transaction").
  • The Board has appointed Robert Galvin as Interim CEO and Director of the Company, effective immediately.
  • Mr. Galvin has significant relevant experience having held operational, financial, and administrative executive leadership roles at both public and private companies prior to joining iAnthus.
  • On May 4, 2022, the OMMU issued a final agency order, accepting the recommendation of the ALJ and dismissing the Petition.

Columbia Care Brings its Most Popular Brands, Seed & Strain and Classix, to Colorado

Retrieved on: 
Thursday, May 5, 2022

Seed & Strain launched in Colorado, its 12th market, on Earth Day with compostable 1g pre-roll tube packaging.

Key Points: 
  • Seed & Strain launched in Colorado, its 12th market, on Earth Day with compostable 1g pre-roll tube packaging.
  • Coloradoans have come to expect the highest quality and most approachable products, and thats exactly what Seed & Strain and Classix offer, said BJ Carretta, SVP of Brand Marketing, Columbia Care.
  • Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.
  • The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD.